Cornering the cultivation of star anise in the name of the common good

Rouche has been condemned by a Boston Globe writer who has never had to pay a payroll or accomplish anything on the free market in his life. The author appears to have stated that the purchase of 90% of the star anise fruit crop is a predatory pricing strategy by Rouche Pharmaceuticals to corner the market for key ingredients in the Tamiflu avian flu vaccine.

If Rouche has requests for bird flu and they do. So they need a way to produce as much as possible. Also, just because they start producing it now doesn’t mean it will be right for the eventual human strain if it ever develops largely as predicted. In other words, we still don’t know what that strain really will be and all of its characteristics. Although we have a very good idea to park it.

If Rouche buys all the star anise fruit and uses his enormous strength to further research or upgrade the facility, that’s a good thing as it will allow them to keep prices down as they have the vertical integration in the market to control that product. not necessarily a pricing strategy. In fact, it may be very good for all of humanity that Rouche is thinking ahead and securing their supply chain for bird flu vaccine now, so when the time comes, they will be ready. Consider this in 2006.